Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 25, 2024 Filed Apr 29, 2024 21:06 UTC |
West NadjaDirector
|
GrantDeferred Share Units · Derivative | 1,385.697 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005334 · doc4.xml · derivative · entry 1 West Nadja · CIK 0001787802 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,093.682 Underlying: Common Stock · 1,385.697 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 21:06 UTC |
Woods Eugene A.Director
|
GrantDeferred Share Units · Derivative | 1,385.697 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005335 · doc4.xml · derivative · entry 1 Woods Eugene A. · CIK 0001762647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,139.143 Underlying: Common Stock · 1,385.697 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 21:06 UTC |
Adamczyk DariusDirector
|
GrantDeferred Share Units · Derivative | 1,385.697 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005336 · doc4.xml · derivative · entry 1 Adamczyk Darius · CIK 0001605056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,712.704 Underlying: Common Stock · 1,385.697 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 21:06 UTC |
HEWSON MARILLYN ADirector
|
GrantDeferred Share Units · Derivative | 1,385.697 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005337 · doc4.xml · derivative · entry 1 HEWSON MARILLYN A · CIK 0001217496 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,173.4414 Underlying: Common Stock · 1,385.697 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.underlying_shares: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 21:06 UTC |
Beckerle Mary CDirector
|
GrantDeferred Share Units · Derivative | 1,385.697 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-005338 · doc4.xml · derivative · entry 1 Beckerle Mary C · CIK 0001520181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,643.012 Underlying: Common Stock · 1,385.697 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| April 25, 2024 Filed Oct 15, 2024 20:39 UTC |
DAVIS D SCOTTDirector
|
GrantDeferred Share Units · Derivative | 1,385.697 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-009300 · doc4.xml · derivative · entry 1 DAVIS D SCOTT · CIK 0001227733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,603.677 Underlying: Common Stock · 1,385.697 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| March 13, 2024 Filed Mar 13, 2024 20:36 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
SaleCommon Stock | 8,891 | $162.16 | $1,441,764.56 |
DisclosureSEC source: 0001225208-24-004185 · doc4.xml · nonDerivative · entry 1 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,043 F1 · price: This transaction was executed in multiple trades at prices ranging from 161.95 to 162.33 . The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:58 UTC |
HEWSON MARILLYN ADirector
|
GrantDeferred Share Units · Derivative | 234.6683 | $159.80 | $37,499.99 |
DisclosureSEC source: 0001225208-24-003852 · doc4.xml · derivative · entry 1 HEWSON MARILLYN A · CIK 0001217496 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,787.7444 Underlying: Common Stock · 234.6683 shares Expires not disclosed F1 · derivative.exercise_price: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. F1 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. F1 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. F2 · balance_after: Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:58 UTC |
Woods Eugene A.Director
|
GrantDeferred Share Units · Derivative | 261.993 | $159.80 | $41,866.48 |
DisclosureSEC source: 0001225208-24-003853 · doc4.xml · derivative · entry 2 Woods Eugene A. · CIK 0001762647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 753.446 Underlying: Common Stock · 261.993 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F2 · derivative.exercise_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. F2 · derivative.expiration_date: Acquisition of Deferred Share Units (DSU) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors. DSUs are to be settled in cash upon termination of the Reporting Person's directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:58 UTC |
Woods Eugene A.Director
|
GrantDeferred Share Units · Derivative | 491.453 | $159.80 | $78,534.19 |
DisclosureSEC source: 0001225208-24-003853 · doc4.xml · derivative · entry 1 Woods Eugene A. · CIK 0001762647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 491.453 Underlying: Common Stock · 491.453 shares Expires not disclosed F1 · derivative.exercise_price: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.exercise_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). F1 · derivative.expiration_date: Grant of Deferred Share Units (DSU) acquired under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each DSU representing the fair market value of one share of Common Stock on the settlement date). Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:54 UTC |
Decker Robert JVP Corporate Controller
|
GrantRestricted Share Units · Derivative | 1,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002527 · doc4.xml · derivative · entry 2 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,016 Underlying: Common Stock · 1,016 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:54 UTC |
Decker Robert JVP Corporate Controller
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 8,175 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002527 · doc4.xml · derivative · entry 1 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,175 Underlying: Common Stock · 8,175 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:54 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantRestricted Share Units · Derivative | 2,519 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002528 · doc4.xml · derivative · entry 2 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,519 Underlying: Common Stock · 2,519 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:54 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 40,551 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002528 · doc4.xml · derivative · entry 1 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,551 Underlying: Common Stock · 40,551 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:54 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
GrantRestricted Share Units · Derivative | 11,046 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002529 · doc4.xml · derivative · entry 2 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,046 Underlying: Common Stock · 11,046 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:54 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 177,816 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002529 · doc4.xml · derivative · entry 1 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,816 Underlying: Common Stock · 177,816 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:54 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
GrantRestricted Share Units · Derivative | 1,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002530 · doc4.xml · derivative · entry 2 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,475 Underlying: Common Stock · 1,475 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:54 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 23,745 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002530 · doc4.xml · derivative · entry 1 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,745 Underlying: Common Stock · 23,745 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
GrantRestricted Share Units · Derivative | 2,883 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002531 · doc4.xml · derivative · entry 2 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,883 Underlying: Common Stock · 2,883 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 46,406 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002531 · doc4.xml · derivative · entry 1 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,406 Underlying: Common Stock · 46,406 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC |
Hait WilliamEVP, Chief EI and Med Officer
|
GrantRestricted Share Units · Derivative | 2,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002532 · doc4.xml · derivative · entry 2 Hait William · CIK 0001904791 · EVP, Chief EI and Med Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,155 Underlying: Common Stock · 2,155 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC |
Hait WilliamEVP, Chief EI and Med Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 34,696 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002532 · doc4.xml · derivative · entry 1 Hait William · CIK 0001904791 · EVP, Chief EI and Med Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,696 Underlying: Common Stock · 34,696 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC |
Swanson James D.EVP, CIO
|
GrantRestricted Share Units · Derivative | 1,475 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002533 · doc4.xml · derivative · entry 2 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,475 Underlying: Common Stock · 1,475 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC |
Swanson James D.EVP, CIO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 23,745 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002533 · doc4.xml · derivative · entry 1 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,745 Underlying: Common Stock · 23,745 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
GrantRestricted Share Units · Derivative | 4,048 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002534 · doc4.xml · derivative · entry 2 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,048 Underlying: Common Stock · 4,048 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC |
REED JOHN CEVP, Innovative Medicine, R&D
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 65,163 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002534 · doc4.xml · derivative · entry 1 REED JOHN C · CIK 0001181561 · EVP, Innovative Medicine, R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,163 Underlying: Common Stock · 65,163 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:56 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
GrantRestricted Share Units · Derivative | 3,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002535 · doc4.xml · derivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,085 Underlying: Common Stock · 3,085 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:56 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 49,658 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002535 · doc4.xml · derivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,658 Underlying: Common Stock · 49,658 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:58 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
GrantRestricted Share Units · Derivative | 4,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002536 · doc4.xml · derivative · entry 2 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,782 Underlying: Common Stock · 4,782 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:58 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 76,981 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002536 · doc4.xml · derivative · entry 1 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,981 Underlying: Common Stock · 76,981 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:56 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
GrantRestricted Share Units · Derivative | 1,819 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002537 · doc4.xml · derivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,819 Underlying: Common Stock · 1,819 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:56 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 29,275 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002537 · doc4.xml · derivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,275 Underlying: Common Stock · 29,275 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC |
Wolk Joseph JExec VP, CFO
|
GrantRestricted Share Units · Derivative | 5,913 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002538 · doc4.xml · derivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,913 Underlying: Common Stock · 5,913 shares Expires 2034-02-15 F2 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to acquire one share of Common Stock. F3 · derivative.exercise_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: The Restricted Share Units vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 15, 2024 Filed Feb 20, 2024 22:55 UTC |
Wolk Joseph JExec VP, CFO
|
GrantEmployee Stock Options (Right to Buy) · Derivative | 95,197 | $0.00 Strike: $157.92 | $0.00 |
DisclosureSEC source: 0001225208-24-002538 · doc4.xml · derivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,197 Underlying: Common Stock · 95,197 shares Expires 2034-02-15 F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionRestricted Share Units · Derivative | 313 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002173 · doc4.xml · derivative · entry 5 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 624 Underlying: Common Stock · 313 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Decker Robert JVP Corporate Controller
|
Tax withholdingCommon Stock | 86 | $157.85 | $13,575.10 |
DisclosureSEC source: 0001225208-24-002173 · doc4.xml · nonDerivative · entry 2 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,973 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionCommon Stock | 313 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002173 · doc4.xml · nonDerivative · entry 1 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionRestricted Share Units · Derivative | 408 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002174 · doc4.xml · derivative · entry 3 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 816 Underlying: Common Stock · 408 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Tax withholdingCommon Stock | 209 | $157.85 | $32,990.65 |
DisclosureSEC source: 0001225208-24-002174 · doc4.xml · nonDerivative · entry 2 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,934 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Broadhurst VanessaEVP, Global Corp Affairs
|
Exercise / conversionCommon Stock | 408 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002174 · doc4.xml · nonDerivative · entry 1 Broadhurst Vanessa · CIK 0001904787 · EVP, Global Corp Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionRestricted Share Units · Derivative | 3,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002175 · doc4.xml · derivative · entry 4 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,939 Underlying: Common Stock · 3,470 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Stock | 1,507 | $157.85 | $237,879.95 |
DisclosureSEC source: 0001225208-24-002175 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,302 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionCommon Stock | 3,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002175 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionRestricted Share Units · Derivative | 925 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002176 · doc4.xml · derivative · entry 3 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,848 Underlying: Common Stock · 925 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Tax withholdingCommon Stock | 474 | $157.85 | $74,820.90 |
DisclosureSEC source: 0001225208-24-002176 · doc4.xml · nonDerivative · entry 2 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,076 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionCommon Stock | 925 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002176 · doc4.xml · nonDerivative · entry 1 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Exercise / conversionRestricted Share Units · Derivative | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002177 · doc4.xml · derivative · entry 3 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,302 Underlying: Common Stock · 651 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Tax withholdingCommon Stock | 236 | $157.85 | $37,252.60 |
DisclosureSEC source: 0001225208-24-002177 · doc4.xml · nonDerivative · entry 2 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,340 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Exercise / conversionCommon Stock | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002177 · doc4.xml · nonDerivative · entry 1 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Hait WilliamSee Remarks
|
Exercise / conversionRestricted Share Units · Derivative | 834 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002178 · doc4.xml · derivative · entry 3 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,666 Underlying: Common Stock · 834 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.